Dyne Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
DYN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1560 Trapelo Road, Waltham, MA

Insiders trading volume in the past year

Dyne Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Atlas Venture Fund XI, L.P. 10%+ Owner $166M Feb 26, 2024
Dirk Kersten Director $158M -$13.8M -8.04% May 30, 2025
Atlas Venture Opportunity Fund I, L.P. 10%+ Owner $69.3M Mar 1, 2024
Atlas Venture Opportunity Fund II, L.P. 10%+ Owner $44.5M Dec 12, 2022
Jason P. Rhodes Director $26.4M -$25.9K -0.1% May 30, 2025
Joshua T. Brumm CEO & President, Director $14M Mar 8, 2024
Wildon Farwell Chief Medical Officer $6.59M Aug 19, 2024
Jonathan McNeill Chief Business Officer $6.08M Aug 19, 2024
Susanna Gatti High Chief Operating Officer $4.53M Sep 18, 2024
John Cox CEO & President, Director $3.58M +$773K +27.5% Sep 5, 2025
Oxana Beskrovnaya Chief Scientific Officer $2.23M -$220K -8.98% Mar 11, 2025
Richard William Scalzo SVP, Head of Finance & Admin. $1.39M -$179K -11.4% Mar 11, 2025
Johanna Friedl-Naderer Chief Commercial Officer $1.27M -$17.5K -1.36% Sep 4, 2025
Douglas Kerr Chief Medical Officer $1.19M -$92.6K -7.25% Sep 4, 2025
Erick Lucera Chief Financial Officer $801K Mar 31, 2025
Brian S. Posner Director $107K Oct 1, 2025
Carlo Incerti Director $0 -$474K -100% May 30, 2025
Catherine Stehman-Breen Director May 30, 2025
David Lubner Director May 30, 2025
Lawrence Otto Klein Director Jul 5, 2022
Edward Hurwitz Director May 30, 2025

Recent Insider Transactions by Companies or Individuals for Dyne Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.